Altos Labs
The AI engine Fit Assessment
BetaAltos Labs is a biotechnology company dedicated to restoring cellular health and resilience through innovative programming techniques. Their mission focuses on reversing diseases and transforming medical practices by leveraging the expertise of leading scientists and clinicians.
Blurb
Altos Labs focuses on cellular rejuvenation programming to restore cell health and resilience, to reverse disease to transform medicine.
HQ Location
San Francisco (United States)
Founded
2021
Employees
340
Total funding raised
$3.00B
Last Funding Event
Series A, $3.00B, January 1, 2021
Smart insights
- Louise Scharf (Director, Pharmacology) worked at 23andMe in various roles, including Director - Immunology, for a total of 5 years (2019 - 2024)
- 6m headcount growth: 3%
- 1Y headcount growth: 9%
- Headcount-to-last-round ratio: 0.2 employees/$M
Operator of a biotechnology company intended to restore cell health and resilience. The company specializes in cellular rejuvenation programming to create a completely new approach to medicine, enabling clients to reverse disease, injury, and disabilities.